Skip to main content
AMGN
NASDAQ Life Sciences

FDA Cuts IMDELLTRA Monitoring Time, Easing Access for Amgen's Lung Cancer Drug

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$378
Mkt Cap
$204.007B
52W Low
$269.77
52W High
$447.03
52W Position info
40% above low
Off High info
15% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AMGN sits 40% above its 52-week low of $269.77.

Summary

The FDA approved a label update for Amgen's IMDELLTRA, reducing required monitoring after the first two infusions from 22-24 hours to 6-8 hours. This lowers the administrative burden and could expand use in community clinics, where 80-85% of U.S. patients are treated. The change directly addresses a key friction point for the drug's uptake in extensive-stage small cell lung cancer. Next-day assessments remain, preserving safety oversight. This follows a period of mixed news for Amgen, including a strong Q2 beat and a recent share drop on competitor data, making this a positive incremental development.

At the time of this announcement, AMGN was trading at $378.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $204B. The 52-week trading range was $269.77 to $447.03. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $458.60 info
Change: -$18.80 (-4%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $458.60 info
Change: -$6.32 (-1%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $458.60 info
Change: -$4.40 (-0.95%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $458.60 info
Change: -$1.97 (-0.43%) info
Market Cap: $248.842B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $458.60 info
Change: +$9.81 (+2%) info
Market Cap: $248.842B info